
Aducanumab for Alzheimer’s Gets FDA Fast-Track Designation
DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments
DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments
MAJOR ADVANCE – VIDEO & ARTICLE: A new experimental drug called “aducanumab” significantly slowed memory, thinking and cognitive decline in Alzheimer’s. It works by almost
DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look
VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making
HEALTH RESEARCH VIDEO + ARTICLE: Can a retinal-scan at an early age predict future development of Alzheimer’s? Can you use that prediction to lessen your
VIDEO + ARTICLE: Aducanumab for Alzheimer’s is showing encouraging results as Phase 3 trials roll out. See how this new immunotherapy is treating Alzheimer’s at
VIDEO + ARTICLE: In an effort to educate potential volunteers to try RVT-101 in a clinical trial, the MINDSET STUDY is trying something new. Doctors
Axovant launches nelotanserin and 3 new clinical programs to treat Lewy body dementia. Also, their drug RVT-101 for Dementia with Lewy Bodies and Alzheimer’s gets
CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy
Many clinical trials for new Alzheimer’s drugs try to clear plaque on the brain. The toxic plaques are made of amyloid-beta. Researchers recently discovered another
Discover compassionate, practical and proven strategies to navigate dementia care confidently, ensuring the well-being of both you and your loved one.
How can military service impact brain health? What are specific risk factors? Are there vital steps soldiers can take towards dementia prevention and treatment?
Salk Institute’s J147 is a derivative of turmeric, a spice used in curry. Learn how it fights memory deficits and has a host of unexpected anti-aging effects in the lab.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor